|
GEMIN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.075600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.884790E-03 |
| Normal-vs-Stage2 |
1.086160E-01 |
| Normal-vs-Stage3 |
3.339400E-01 |
| Normal-vs-Stage4 |
3.261800E-01 |
| Stage1-vs-Stage2 |
8.436200E-01 |
| Stage1-vs-Stage3 |
3.015700E-02 |
| Stage1-vs-Stage4 |
1.605800E-02 |
| Stage2-vs-Stage3 |
7.227800E-02 |
| Stage2-vs-Stage4 |
1.247380E-01 |
| Stage3-vs-Stage4 |
7.133600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.131700E-02 |
| Normal-vs-AfricanAmerican |
1.890420E-02 |
| Normal-vs-Asian |
8.774000E-01 |
| Caucasian-vs-AfricanAmerican |
3.775400E-01 |
| Caucasian-vs-Asian |
5.665800E-01 |
| AfricanAmerican-vs-Asian |
3.182800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.194800E-04 |
| Normal-vs-Female |
1.238180E-01 |
| Male-vs-Female |
1.415470E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.864600E-01 |
| Normal-vs-Extreme_Weight |
7.751200E-04 |
| Normal-vs-Obese |
5.359600E-01 |
| Normal-vs-Extreme_Obese |
3.722100E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.829250E-01 |
| Normal_Weight-vs-Obese |
8.370200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.112200E-01 |
| Extreme_Weight-vs-Obese |
4.503600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.775200E-01 |
| Obese-vs-Extreme_Obese |
1.837990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.995200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.063800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.230200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.425700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.264800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.668000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.674500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.604400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.669800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.880200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.22000000000122E-05 |
| Normal-VS-Type2 PRCC |
8.781400E-01 |
| Normal-VS-KIRP CIMP |
4.893800E-01 |
| Normal-VS-Unclassified PRCC |
7.566600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.090440E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.372200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.228400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.306200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.745000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.971600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.062300E-02 |
| Normal-vs-N1 |
4.214500E-02 |
| Normal-vs-N2 |
4.856600E-01 |
| N0-vs-N1 |
2.476200E-03 |
| N0-vs-N2 |
2.144800E-01 |
| N1-vs-N2 |
7.612000E-01 |
|
|
